Authors


Patricia Clark, CNP

Latest:

Improving Medication Management and Education of Parkinson Disease in Hospital Settings: Patricia Clark, CNP

The nurse practitioner at the Cleveland Clinic talked about findings from a recent study focused on enhancing medication management and education for patients with Parkinson disease. [WATCH TIME: 5 minutes]


Robert G. Holloway, MD, MPH

Latest:

AUPN Leadership Minute Episode 22: Sharing Leadership: How to Select Vice-Chairs

Episode 23 of the AUPN Leadership Minute features Donald S. Higgins, Jr., MD, of the VHA and Albany Medical College; and Robert Holloway, MD, MPH, of University of Rochester School of Medicine and Dentistry. [WATCH TIME: 6 minutes]


John Michael Schreiber, MD

Latest:

Insights From the Pediatric Epilepsy Research Consortium on Advancing Genetic Testing

A duo of experts discussed the importance of addressing barriers such as provider comfort, access to genetic counselors, and insurance coverage to reduce diagnostic latency and standardize genetic testing for epilepsy. [WATCH TIME: 5 minutes]


Asaff Harel, MD

Latest:

Asaff Harel, MD: Risk Factors for Severe COVID-19 Infection in Multiple Sclerosis

The neurologist at Lenox Hill Hospital detailed the findings of his observational study that looked at patterns of COVID-19 infections in patients with multiple sclerosis.


Sharon Fekrat, MD

Latest:

Using Artificial Intelligence and Retinal Imaging to Detect Neurodegenerative Diseases Early: Sharon Fekrat, MD

The professor of ophthalmology and neurology at Duke University School of Medicine talked about a recent published study on using artificial intelligence and retinal scans to detect mild cognitive impairment in neurodegenerative diseases including Alzheimer disease. [WATCH TIME: 7 minutes]


Eric Olson, MD

Latest:

Raising Awareness on Insomnia, Asking Patients About Their Sleep: Eric Olson, MD

In honor of Insomnia Awareness Night, the president of the American Academy of Sleep Medicine board of directors talked about increasing awareness of the sleep disorder for the clinical and patient community. [WATCH TIME: 6 minutes]


Kevin Swong, MD

Latest:

Emerging Considerations in Peripheral Nerve Injury and Surgical Intervention: Kevin Swong, MD

The neurosurgeon at Northwestern Medicine discussed diagnostic approaches, evolving treatment strategies, and the importance of timely referral in managing peripheral nerve injuries. [WATCH TIME: 3 minutes]


Anna Castagna, MD

Latest:

The Need for Flexibility and Patient-Centered Approaches in Clinical Trials for Cervical Dystonia: Anna Castagna, MD

The consultant neurologist at Fondazione Don Carlo Gnocchi ONLUS stressed how new clinical trial designs for cervical dystonia should incorporate more flexible and patient-centered approaches, including new measurement scales and the use of technology. [WATCH TIME: 5 minutes]


Tarun Singhal, MD, MBBS

Latest:

Promising Nasal Administration Treatment for Non-Active Secondary Progressive MS: Tarun Singhal, MD, MBBS

The director of the PET Imaging Program in Neurologic Diseases at Brigham and Women’s Hospital talked about nasal administration of foralumab that shows promise in treating patients with non-active secondary progressive MS. [WATCH TIME: 5 minutes]


Neel Fotedar, MD

Latest:

Investigating Limb Swelling in Patients With Dravet Syndrome: Mandy Alhajj, DO, James Dolbow, DO & Neel Fotedar, MD

A trio of experts from university hospitals discussed a study that aimed to uncover the prevalence and associations of limb swelling in patients with Dravet syndrome in hopes of improving care. [WATCH TIME: 5 minutes]


Elyse Stock, MD

Latest:

Collecting Drug-Drug Interaction Data on Rimegepant: Elyse Stock, MD

The chief medical officer of Biohaven Pharmaceuticals discussed the findings of an assessment of rimegepant (Nurtec ODT) exposure with concomitant administration of inhibitors of P-gp and BCRP transporters.


Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP

Latest:

Advice for Advanced Practice Providers in Managing Sleep Disorders

Advanced practice practitioners share final pearls with their colleagues for the management of sleep disorders.


Oliver Tobin, MBBCh, BAO, PhD

Latest:

Ongoing Research in MS Differentiation: Oliver Tobin, MBBCh, BAO, PhD

The associate professor of neurology at Mayo Clinic Rochester discusses technological advancements and research efforts in relation to differential multiple sclerosis.


Ahmed Abdelhak, MD

Latest:

Conversations on Biomarker Use in Multiple Sclerosis Remyelination Research

Ahmed Abdelhak, MD, assistant professor of neurology at the UCSF, discussed the evolving landscape of biomarkers in multiple sclerosis and their potential to transform remyelination approaches.


Jeffrey Guptill, MD, MS, MHS

Latest:

Nipocalimab Shows Promise as Myasthenia Gravis Treatment: Jeffrey Guptill, MD, MS, MHS

The associate professor of neurology and neurologist at Duke University discussed the positive results of nipocalimab, a monoclonal antibody, in patients with myasthenia gravis.


Ditte Primdahl, MD

Latest:

Evolving Approaches to the Diagnosis and Management of Paraneoplastic Neurologic Syndromes: Ditte Primdahl, MD; Shailee Samir Shah, MD

A duo of experts from Feinberg School of Medicine discussed the growing role of clinical algorithms, risk stratification, and treatment considerations in managing paraneoplastic neurologic syndromes alongside cancer therapies. [WATCH TIME: 4 minutes]


Lauren Chamberlain, DO

Latest:

Patient Evaluation for Excessive Daytime Sleepiness

Excessive daytime sleepiness is a hallmark of a number of sleep disorders, and ensuring the proper diagnosis and management of those presenting with it is crucial to care.


Lucas Donovan, MD, MS

Latest:

Takeaways From Telehealth Use in Sleep Medicine: Lucas Donovan, MD, MS

The assistant professor in the division of pulmonary, critical care, and sleep medicine at the University of Washington discussed patients’ response to the use of telehealth when treating sleep disorders. [WATCH TIME: 2 minutes]


Lindsey Lee Lair, MD

Latest:

Mechanistic Potential of Taldefgrobep Alfa in Spinal Muscular Atrophy: Lindsey Lee Lair, MD

The vice president of clinical development at Biohaven shed light on a newly initiated phase 3 study evaluating a promising agent for patients with all types of spinal muscular atrophy. [WATCH TIME: 2 minutes]


Michael Yeaman, PhD

Latest:

R&D for NMOSD Therapies

Drs Mirla Avila, Mitzi Williams, Michael Levy, and Michael Yeaman comment on research and development priorities for clinical care and emerging therapies for NMOSD.



David Kudrow, MD

Latest:

Acute and Preventative Migraine Treatment: Advice for Neurologists

Dr David Kudrow shares some advice for community neurologists on the acute and preventive treatment of migraine.


Lucretia Long, APRN-CNP

Latest:

Interdisciplinary Care Teams in Epilepsy Care: Lucretia Long, APRN-CNP

The associate clinical professor of neurology at OSU Wexner Medical Center discussed the state of interdisciplinary care for individuals with epilepsy, and how these care teams operate. [WATCH TIME: 2 minutes]


Michael Yassa, PhD

Latest:

Uncovering the Impact of Social Determinants on the Risk of Alzheimer Disease: Michael Yassa, PhD

The professor of neurology at the University of California, Irvine, talked about social determinants of health in Alzheimer disease and the importance of having diverse populations in clinical trials. [WATCH TIME: 4 minutes]


Grace Griesbach, PhD

Latest:

Sex Dependent Decreases in REM Sleep After TBI and the Impact it May Have on Recovery

Grace Griesbach, PhD, the national director of clinical research for Centre for Neuro Skills, discussed the impact of REM sleep on memory following traumatic brain injury and the importance of considering sex as a biological variable.


Takeshi Iwatsubo, MD, PhD

Latest:

Early Clinical Use of Anti-Amyloid Therapy for Alzheimer Disease in Japan: Takeshi Iwatsubo, MD, PhD

The professor of neuropathology at the University of Tokyo School of Medicine talked about the latest data on lecanemab use in clinical practice for Alzheimer disease in Japan presented at CTAD 2024. [WATCH TIME: 4 minutes]


Tuan Vu, MD

Latest:

Clinical Pearls for CIDP Management

Panelists discuss how physicians can improve outcomes for patients with chronic inflammatory demyelinating polyneuropathy (CIDP) by prioritizing early and accurate diagnosis, personalizing treatment plans, regularly monitoring patients, and addressing the psychological and emotional impact of the disease.


Laurent Servais, MD, PhD

Latest:

Flaws in Assessment Scales for Neuromuscular Conditions: Laurent Servais, MD, PhD

The professor of pediatric neuromuscular diseases at the University of Oxford provided commentary on the commonly used scales to assess neuromuscular function and where inconsistencies have been observed. [WATCH TIME: 7 minutes]


Stephen L. Hauser, MD

Latest:

Stephen L. Hauser, MD: Fenebrutinib and BTK Inhibition in Progressive MS

The director of the UCSF Weill Institute for Neuroscience spoke to the advantages of having agents that can be used across the spectrum of MS, and the role disease progression plays early on.


Olivia Begasse de Dhaem, MD, FAHS

Latest:

Debunking Myths of Migraine’s Role in Dementia: Olivia Begasse de Dhaem, MD, FAHS

The headache specialist at Hartford Healthcare Headache Center emphasized the importance of avoiding unnecessary fear surrounding the potential link between migraine and dementia, as current evidence does not strongly support it being a significant risk factor. [WATCH TIME: 2 minutes]

© 2025 MJH Life Sciences

All rights reserved.